Hyperglycemic crises in adults: A look at the 2024 consensus report
Cleveland Clinic Journal of Medicine · 2025-03 · 92 (3) · 152-158
DOI: 10.3949/ccjm.92a.24089 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cleveland Clinic Journal of Medicine, online erschienen am 03.03.2025. Verfasst von Paloma Rodriguez Alvarez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Visiting Assistant Professor, Department of Medicine, Clevela…. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Hyperglycemia, Hyperglycemic Hyperosmolar Nonketotic Coma. Die Arbeit wurde bisher 12-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Visiting Assistant Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve Universit…
- Department of Endocrinology and Diabetes, Macromédica Dominicana, Santo Domingo, Dominican Republic.
- Director of Inpatient Diabetes Service, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH.
Zitieren
APA
Rodriguez Alvarez, P., San Martin, V. T., & Morey-Vargas, O. L. (2025). Hyperglycemic crises in adults: A look at the 2024 consensus report. Cleveland Clinic Journal of Medicine, 92(3), 152-158. https://doi.org/10.3949/ccjm.92a.24089
Vancouver
Rodriguez Alvarez P, San Martin VT, Morey-Vargas OL. Hyperglycemic crises in adults: A look at the 2024 consensus report. Cleveland Clinic Journal of Medicine. 2025;92(3):152-158. doi:10.3949/ccjm.92a.24089
BibTeX
@article{RodriguezAlvarez2025,
author = {Rodriguez Alvarez, Paloma and San Martin, Vicente T and Morey-Vargas, Oscar L},
title = {Hyperglycemic crises in adults: A look at the 2024 consensus report},
journal = {Cleveland Clinic Journal of Medicine},
year = {2025},
volume = {92},
number = {3},
pages = {152--158},
doi = {10.3949/ccjm.92a.24089}
}
EUVIMED